information, please visit the homepage www.RESIST-cluster.de. SERVICE: For further information, please contact Professor Dr Nico Lachmann, Lachmann.Nico@mh-hannover.de , telephone (0511) 532-5366.

academic self-administration were of great concern to him. Even after his retirement, he kept in close contact with "his" hospital and was often a guest there. He remembered the beginnings in Hanover with particular

euros over 36 months, will start at the beginning of 2023. SERVICE: For further information , please contact Professor Dr Sascha David, david.sascha@mh-hannover.de , and Privatdozent Dr Klaus Stahl, stahl.

in standard care to all seriously ill children in the future." SERVICE: For more information , contact Dr. Bernd Auber, auber.bernd@mh-hannover.de , phone (0511) 532-8719.

waiting for the MLIV.K and MLIV.A gene taxis in the future. SERVICE: For further information , please contact Professor Dr Hildegard Büning, buening.hildegard@mh-hannover.de , telephone (0511) 532-5106. The

therapy-resistant pulmonary arterial hypertension (PAH). SERVICE For further information , please contact Professor Dr. Georg Hansmann, telephone (0511) 532-9594, hansmann.georg@mh-hannover.de . The original

injury, for which there is currently no specific treatment. SERVICE: For further information , please contact Professor Dr. Dr. Thomas Thum, thum.thomas@mh-hannover.de , telephone (0511) 532-9174.

for the use of MYGDF as a new drug for heart failure. SERVICE: For further information , please contact Professor Dr. Kai Wollert, wollert.kai@mh-hannover.de , telephone (0511) 532-4055. The original paper

is well prepared for the future in terms of logistics. SERVICE: For further information , please contact Andreas Kohlhase, kohlhase.andreas@mh-hannover.de , telephone (0511) 532-6647.

acquisition of our RNA-based spin-off company Cardior Pharmaceuticals GmbH by Novo Nordisk (2024). Contact: XXXX Viereck, J., Bührke, A., Foinquinos, A., Chatterjee, S., Kleeberger, JA., Xiao, K., Janssen-Peters